See how Baysient’s T3 application supports precision dosing for a 20 kg patient on Infliximab IV therapy. This walkthrough demonstrates how T3 provides gastroenterologists with actionable insights to adjust dosing regimens for smaller adult or adolescent patients requiring a personalized approach.

Key highlights include:

✔ How to input critical patient-specific data, such as weight, observed trough levels, and target concentrations.

✔ Generating customized nomograms to identify optimal doses and dosing intervals.

✔ Using predictive probability charts to assess risks like anti-drug antibody development and evaluate remission potential.

Watch the video to discover how T3 enables precision dosing, helping gastroenterologists improve patient outcomes with data-driven adjustments to standard dosing intervals.